Literature DB >> 12459396

In regard to Donaldson et al: results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma-a report from the IRSG. IJROBP 2001;51:718-728.

Robert D Timmerman, Marc Mendonca.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 12459396     DOI： 10.1016/s0360-3016(02)03015-8

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  4 in total

1.  Local failure in parameningeal rhabdomyosarcoma correlates with poor response to induction chemotherapy.

Authors:  Matthew M Ladra; Henry C Mandeville; Andrzej Niemierko; Timothy P Padera; Alison M Friedmann; Shannon M MacDonald; David Ebb; Yen-Lin Chen; Nancy J Tarbell; Torunn I Yock
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-04-08       Impact factor: 7.038

2.  The Organ Sparing Potential of Different Biological Optimization Strategies in Proton Therapy.

Authors:  Helge Henjum; Tordis J Dahle; Lars Fredrik Fjæra; Eivind Rørvik; Sara Pilskog; Camilla H Stokkevåg; Andrea Mairani; Kristian S Ytre-Hauge
Journal:  Adv Radiat Oncol       Date:  2021-08-17

Review 3.  Radioresistance in rhabdomyosarcomas: Much more than a question of dose.

Authors:  Simona Camero; Matteo Cassandri; Silvia Pomella; Luisa Milazzo; Francesca Vulcano; Antonella Porrazzo; Giovanni Barillari; Cinzia Marchese; Silvia Codenotti; Miriam Tomaciello; Rossella Rota; Alessandro Fanzani; Francesca Megiorni; Francesco Marampon
Journal:  Front Oncol       Date:  2022-09-29       Impact factor: 5.738

Review 4.  The alfa and beta of tumours: a review of parameters of the linear-quadratic model, derived from clinical radiotherapy studies.

Authors:  C M van Leeuwen; A L Oei; J Crezee; A Bel; N A P Franken; L J A Stalpers; H P Kok
Journal:  Radiat Oncol       Date:  2018-05-16       Impact factor: 3.481
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.